Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 15324743

CD46: expanding beyond complement regulation.

Rebecca C Riley-Vargas·Darcy B Gill·Claudia Kemper·M Kathryn Liszewski·John P Atkinson
View original source ↗Export metadata ↓

Abstract

During the 1980s CD46 was discovered in a search for C3b binding proteins of human peripheral blood cells. Its role as an inactivator of C3b and C4b deposited on self-tissue is highlighted by the observation that partial deficiency of CD46 is a predisposing factor to hemolytic uremic syndrome. This discovery has an impact on the treatment options for these patients. Other new findings have expanded the role of CD46 in immunity and disease. For example, signaling through CD46 on human T lymphocytes drives them to become regulatory cells, indicating a novel link between the complement system and cellular immunity. Also, CD46 interacts with at least seven human pathogens and participates in reproduction/fertilization, further suggesting that dissecting its multi-faceted activities will have important clinical implications.

Explore related subjects

Anemia, HemolyticAnimalsAntigens, CDComplement System ProteinsHumansMembrane Cofactor ProteinMembrane GlycoproteinsSignal TransductionT-LymphocytesJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Rebecca C Riley-Vargas, Darcy B Gill, Claudia Kemper, M Kathryn Liszewski, John P Atkinson. 2004. CD46: expanding beyond complement regulation.. https://doi.org/10.1016/j.it.2004.07.004

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Alleviation of hemolysis after the stent implantation into an obstructed extracardiac conduit.

An 11-year-old boy who had undergone extracardiac conduit repair for the corrected transposition of the great arteries at 1 year of age showed hemolytic anemia due to a significant stenosis of the conduit placed between the right ventricle and pulmonary artery. There was a pressure gradient of 157 mmHg across the stenosis, giving 1.6:1 of right to left ventricular pressure ratio. Hemoglobin was 93 g/L with increased serum lactate dehydrogenase of 1382 IU/L. Stent implantation into this obstructed conduit has decreased a pressure gradient to 45 mmHg, leaving 0.74 of right to left ventricular pressure ratio. At 3 months after the stent implantation, hemoglobin has normalized. This case illustrate that an extremely severe stenosis of the right ventricular extracardiac conduit can induce hemolytic anemia and stent implantation into the conduit can be one of the alternative treatments to alleviate conduit stenosis and stop hemolysis.

Anemia, Hemolytic↗
PubMed2005

Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia.

We have investigated the effects of coexpression of protein 4.2 and three protein-4.2 variants with band 3 in the Xenopus oocyte expression system. Normal protein 4.2 increased band-3-specific chloride transport in the oocytes. Protein 4.2 also coimmunoprecipitated with band 3 and colocalized with band 3 at the oocyte plasma membrane. The increase in band-3-mediated chloride transport and coimmunoprecipitation of protein 4.2 required the presence of the N-terminal cytoplasmic domain of band 3. Protein 4.2 also localized to the oocyte plasma membrane in the absence of band 3. The protein-4.2 variants 4.2 Tozeur (R310Q) and 4.2 Komatsu (D175Y) had impaired ability to bind to band 3 and these variants did not localize to the oocyte plasma membrane when expressed on their own or when coexpressed with band 3. Unexpectedly, 4.2 Nippon (A142T) behaved similarly to normal protein 4.2. In the absence of a crystal structure of protein 4.2, we propose a homology model of protein 4.2 based on the structure of the sequence-related protein transglutaminase. Using our results in oocytes and this homology model we speculate how these mutations affect protein 4.2 and result in hereditary spherocytosis.

Anemia, Hemolytic↗